Middle East & Africa Hormone Replacement Therapy Market Size & Outlook
Related Markets
MEA hormone replacement therapy market highlights
- The MEA hormone replacement therapy market generated a revenue of USD 863.3 million in 2024.
- The market is expected to grow at a CAGR of 6.5% from 2025 to 2033.
- In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2024.
- HGH replacement therapy is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 863.3 million |
| Market revenue in 2033 | USD 1,508.4 million |
| Growth rate | 6.5% (CAGR from 2025 to 2033) |
| Largest segment | Estrogen and progesterone replacement therapy |
| Fastest growing segment | HGH replacement therapy |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
| Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.7% of the global hormone replacement therapy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,887.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormone Replacement Therapy Market Scope
Hormone Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ascend Wellness Holdings Inc | View profile | 1500 | 1411 Broadway, 16th Floor, New York, NY, United States, 10018 | https://www.awholdings.com |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | http://www.hisamitsu.co.jp |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Middle East & Africa hormone replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 62.09% in 2024. Horizon Databook has segmented the Middle East & Africa hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2021 to 2033.
Middle Eastern countries, such as Saudi Arabia, Qatar, UAE, Kuwait, and Oman, are prospering economies. Advancements in healthcare systems are expected t o increase the demand for hormonal replacement drugs in this region.
In coordination with WHO or other independent organizations, governments of these countries are undertaking several initiatives for the advancement of healthcare sector in the region. This is expected to help in the development of the market in the near future.
These regions face issues of social stigma and lack of healthcare infrastructure, which is also expected to restrain the regional hormonal replacement therapy market.
Reasons to subscribe to Middle East & Africa hormone replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa hormone replacement therapy market databook
-
Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa hormone replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa hormone replacement therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA hormone replacement therapy market size, by country, 2021-2033 (US$M)
Middle East & Africa Hormone Replacement Therapy Market Outlook Share, 2024 & 2033 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
